Market TodayThemes and Stocks SummaryThematic Stock SearchDaily Refresh Schedule
APRE - Aprea Therapeutics Inc
-0.15(-3.49%)6:00:00 PM 11/26/2021
Aprea Therapeutics, Inc., a biopharmaceutical company, develops and commercializes cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its lead product candidate is APR-246, a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes and acute myeloid leukemia. The company was founded in 2006 and is headquartered in Boston, Massachusetts.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 


Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.


  • Volatility is at a recent 2 week high. A high volatility of stock movement indicates uncertainty.
Stock Statistics
PE Ratio
PEG Ratio
P/S (ttm)
Earning Growth (QoQ)
Revenue Growth (QoQ)
Short %28%
Held by Institutions %57%
1 Day Vol Adjusted Return-1.1
1 Month Vol Adjusted Return-4.7
3 Month Vol Adjusted Return-0.9
6 Month Vol Adjusted Return-0.5
20 Days SMA Price ZScore-1.5
50 Days SMA Price ZScore-2.1
12 -26 Days PPO-4.9
1 Month Average Short Volume Ratio29.7
1 Day Volume Change ZScore-1.6
1 Month Daily Vol3.2
Related Topics

Related Peers

Stock news